Literature DB >> 19918911

Altered lumbar spine structure, biochemistry, and biomechanical properties in a canine model of mucopolysaccharidosis type VII.

Lachlan J Smith1, John T Martin, Spencer E Szczesny, Katherine P Ponder, Mark E Haskins, Dawn M Elliott.   

Abstract

Mucopolysaccharidosis VII (MPS VII) is a lysosomal storage disorder characterized by a deficiency in beta-glucuronidase activity, leading to systemic accumulation of poorly degraded glycosaminoglycans (GAG). Along with other morbidities, MPS VII is associated with pediatric spinal deformity. The objective of this study was to examine potential associations between abnormal lumbar spine matrix structure and composition in MPS VII, and spine segment and tissue-level mechanical properties, using a naturally occurring canine model with a similar clinical phenotype to the human form of the disorder. Segments from juvenile MPS VII and unaffected dogs were allocated to: radiography, gross morphology, histology, biochemistry, and mechanical testing. MPS VII spines had radiolucent lesions in the vertebral body epiphyses. Histologically, this corresponded to a GAG-rich cartilaginous region in place of bone and elevated GAG staining was seen in the annulus fibrosus. Biochemically, MPS VII samples had elevated GAG in the outer annulus fibrosus and epiphyses, low calcium in the epiphyses, and high water content in all regions except the nucleus pulposus. MPS VII spine segments had higher range of motion and lower stiffness than controls. Endplate indentation stiffness and failure loads were significantly lower in MPS VII samples, while annulus fibrosus tensile mechanical properties were normal. Vertebral body lesions in MPS VII spines suggest a failure to convert cartilage to bone during development. Low stiffness in these regions likely contributes to mechanical weakness in motion segments and is a potential factor in the progression of spinal deformity. Copyright (c) 2009 Orthopaedic Research Society.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19918911      PMCID: PMC2975604          DOI: 10.1002/jor.21030

Source DB:  PubMed          Journal:  J Orthop Res        ISSN: 0736-0266            Impact factor:   3.494


  32 in total

1.  Intervertebral disc mechanics are restored following cyclic loading and unloaded recovery.

Authors:  Wade Johannessen; Edward J Vresilovic; Alexander C Wright; Dawn M Elliott
Journal:  Ann Biomed Eng       Date:  2004-01       Impact factor: 3.934

2.  Effect of fiber orientation and strain rate on the nonlinear uniaxial tensile material properties of tendon.

Authors:  Heather Anne Lynch; Wade Johannessen; Jeffrey P Wu; Andrew Jawa; Dawn M Elliott
Journal:  J Biomech Eng       Date:  2003-10       Impact factor: 2.097

3.  Beta glucuronidase deficiency: report of clinical, radiologic, and biochemical features of a new mucopolysaccharidosis.

Authors:  W S Sly; B A Quinton; W H McAlister; D L Rimoin
Journal:  J Pediatr       Date:  1973-02       Impact factor: 4.406

4.  A new method for determining micro quantities of calcium in biological materials.

Authors:  B C Sarkar; U P Chauhan
Journal:  Anal Biochem       Date:  1967-07       Impact factor: 3.365

Review 5.  Animal models for mucopolysaccharidoses and their clinical relevance.

Authors:  M Haskins; M Casal; N M Ellinwood; J Melniczek; H Mazrier; U Giger
Journal:  Acta Paediatr Suppl       Date:  2002

6.  Beta-glucuronidase deficiency in a dog: a model of human mucopolysaccharidosis VII.

Authors:  M E Haskins; R J Desnick; N DiFerrante; P F Jezyk; D F Patterson
Journal:  Pediatr Res       Date:  1984-10       Impact factor: 3.756

7.  Variation in the phenotypic expression of beta-glucuronidase deficiency.

Authors:  A L Beaudet; N M DiFerrante; G D Ferry; B L Nichols; C E Mullins
Journal:  J Pediatr       Date:  1975-03       Impact factor: 4.406

8.  Neonatal retroviral vector-mediated hepatic gene therapy reduces bone, joint, and cartilage disease in mucopolysaccharidosis VII mice and dogs.

Authors:  Robert L Mango; Lingfei Xu; Mark S Sands; Carole Vogler; Gabriela Seiler; Tobias Schwarz; Mark E Haskins; Katherine Parker Ponder
Journal:  Mol Genet Metab       Date:  2004-05       Impact factor: 4.797

Review 9.  Enzyme replacement therapy for lysosomal storage disorders: successful transition from concept to clinical practice.

Authors:  William S Sly
Journal:  Mo Med       Date:  2004 Mar-Apr

10.  CD44 deficiency improves healing tendon mechanics and increases matrix and cytokine expression in a mouse patellar tendon injury model.

Authors:  Heather L Ansorge; Pedro K Beredjiklian; Louis J Soslowsky
Journal:  J Orthop Res       Date:  2009-10       Impact factor: 3.494

View more
  17 in total

1.  Delayed hypertrophic differentiation of epiphyseal chondrocytes contributes to failed secondary ossification in mucopolysaccharidosis VII dogs.

Authors:  Sun H Peck; Philip J M O'Donnell; Jennifer L Kang; Neil R Malhotra; George R Dodge; Maurizio Pacifici; Eileen M Shore; Mark E Haskins; Lachlan J Smith
Journal:  Mol Genet Metab       Date:  2015-09-26       Impact factor: 4.797

2.  The effect of neonatal gene therapy on skeletal manifestations in mucopolysaccharidosis VII dogs after a decade.

Authors:  Elizabeth M Xing; Van W Knox; Patricia A O'Donnell; Tracey Sikura; Yuli Liu; Susan Wu; Margret L Casal; Mark E Haskins; Katherine P Ponder
Journal:  Mol Genet Metab       Date:  2013-04-06       Impact factor: 4.797

3.  Molecular profiling of failed endochondral ossification in mucopolysaccharidosis VII.

Authors:  Sun H Peck; John W Tobias; Eileen M Shore; Neil R Malhotra; Mark E Haskins; Margret L Casal; Lachlan J Smith
Journal:  Bone       Date:  2019-08-20       Impact factor: 4.398

4.  Effect of neonatal gene therapy on lumbar spine disease in mucopolysaccharidosis VII dogs.

Authors:  Lachlan J Smith; John T Martin; Patricia O'Donnell; Ping Wang; Dawn M Elliott; Mark E Haskins; Katherine P Ponder
Journal:  Mol Genet Metab       Date:  2012-03-29       Impact factor: 4.797

5.  Pathogenesis of lumbar spine disease in mucopolysaccharidosis VII.

Authors:  Lachlan J Smith; Guilherme Baldo; Susan Wu; Yuli Liu; Michael P Whyte; Roberto Giugliani; Dawn M Elliott; Mark E Haskins; Katherine P Ponder
Journal:  Mol Genet Metab       Date:  2012-03-30       Impact factor: 4.797

6.  Surgical management of thoracolumbar kyphosis in mucopolysaccharidosis type 1 in a reference center.

Authors:  Kariman Abelin Genevois; Christophe Garin; Federico Solla; Nathalie Guffon; Rémi Kohler
Journal:  J Inherit Metab Dis       Date:  2013-06-29       Impact factor: 4.982

Review 7.  Pathogenesis and treatment of spine disease in the mucopolysaccharidoses.

Authors:  Sun H Peck; Margret L Casal; Neil R Malhotra; Can Ficicioglu; Lachlan J Smith
Journal:  Mol Genet Metab       Date:  2016-06-04       Impact factor: 4.797

8.  Postnatal progression of bone disease in the cervical spines of mucopolysaccharidosis I dogs.

Authors:  Joseph A Chiaro; Matthew D Baron; Chelsea M Del Alcazar; Patricia O'Donnell; Eileen M Shore; Dawn M Elliott; Katherine P Ponder; Mark E Haskins; Lachlan J Smith
Journal:  Bone       Date:  2013-04-04       Impact factor: 4.398

9.  Structural, compositional, and biomechanical alterations of the lumbar spine in rats with mucopolysaccharidosis type VI (Maroteaux-Lamy syndrome).

Authors:  Alon Lai; Calogera M Simonaro; Edward H Schuchman; Yi Ge; Damien M Laudier; James C Iatridis
Journal:  J Orthop Res       Date:  2012-11-28       Impact factor: 3.494

Review 10.  Failures of Endochondral Ossification in the Mucopolysaccharidoses.

Authors:  Zhirui Jiang; Sharon Byers; Margret L Casal; Lachlan J Smith
Journal:  Curr Osteoporos Rep       Date:  2020-10-16       Impact factor: 5.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.